{"sourcedb":"DevicePMAs@therightstef","sourceid":"P970018_S003","text":"Approval for name changes from autocyte prep system to prepstain system and from cytorich to surepath.  The device, as modified, will be marketed under the trade names prepstain system and surepath.  The prepstain system and surepath is indicated as a liquid-based, thin layer cell preparation process.  The prepstain system produces slides that are intended as replacements for conventional gynecologic pap smears.  The prepstain slides are intended for use in the screening and detection of cervical cancer, precancerous lesions, atypical cells and all other cytologic categories as defined by the bethesda system for reporting cervical/vaginal cytologic diagnoses.","project":"consensus_PMA_Age_Indications"}